Intralesional interferon alfa-2b treatment of keratoacanthomas

Journal of the American Academy of Dermatology

Volumn 51, Issue 5 SUPPL., 2004, Pages S177-S180

  Oh, Chang Keun ^a   Son, Hyo Sung ^a   Lee, Jae Bong ^a   Jang, Ho Sun ^a   Kwon, Kyung Sool ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT ALPHA2B INTERFERON; ALPHA2B INTERFERON;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTHRALGIA; ARTICLE; CANCER INHIBITION; CASE REPORT; CHILL; DRUG EFFECT; DRUG FEVER; FEMALE; FOLLOW UP; HEADACHE; HUMAN; KERATOACANTHOMA; LIP TUMOR; LOWER LIP; MALAISE; MALE; MEDICAL PHOTOGRAPHY; MYALGIA; NAUSEA; NECK TUMOR; PILOT STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION; CHEEK; CHEMICALLY INDUCED DISORDER; FEVER; INTRALESIONAL DRUG ADMINISTRATION; LIP DISEASE; MIDDLE AGED; NECK; PAIN;

AGED; CHEEK; CHILLS; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; INTERFERON ALFA-2B; KERATOACANTHOMA; LIP DISEASES; MALE; MIDDLE AGED; NECK; PAIN; PILOT PROJECTS;

EID: 16644397926     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.05.009     Document Type: Article

References (13)

1. R.A. Schwartz Keratoacanthoma J Am Acad Dermatol 30 1994 1 19
2. M. Goebeler, C. Lurz, M.E. Kolve-Goebeler, and E.B. Brocker Pancytopenia after treatment of keratoacanthoma by single lesional methotrexate infiltration Arch Dermatol 137 2001 1104 1105
3. K. Asadullah, W. Sterry, and U. Trefzer Cytokine: interleukin and interferon therapy in dermatology Clin Exp Dermatol 27 2002 578 584
4. L. Wickramasinghe, T.C. Hindson, and H. Wacks Treatment of neoplastic skin lesions with intralesional interferon J Am Acad Dermatol 20 1989 71 74
5. J.J. Grob, F. Suzini, M.A. Richard, M. Weiller, H. Zarour, and C. Noe Large keratoacanthomas treated with intralesional interferon alfa-2a J Am Acad Dermatol 29 1993 237 242
6. B. Somlai, and P. Hollo Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma Hautarzt 51 2000 173 175
7. G.K. McEvoy AHFS drug information 2002 2002 American Society of Health-System Pharmacists Bethesda (MD) p.1036-661
8. D.L. Brassard, M.J. Grace, and R.W. Bordens Interferon-alpha as an immunotherapeutic protein J Leukoc Biol 71 2002 565 581
9. L. Edwards, D. Whiting, D. Rogers, K. Luck, and K.A. Smiles The effect of intralesional interferon gamma on basal cell carcinomas J Am Acad Dermatol 22 1990 496 500
10. H.T. Greenway, R.C. Cornell, D.J. Tanner, E. Peets, G.M. Bordin, and C. Nagi Treatment of basal cell carcinoma with intralesional interferon J Am Acad Dermatol 15 1986 437 443
11. F. Belardelli, M. Ferrantini, E. Proietti, and J.M. Kirkwood Interferon-alpha in tumor immunity and immunotherapy Cytokine Growth Factor Rev 13 2002 119 134
12. E.D. Hsi, S.M. Svoboda-Newman, R.A. Stern, B.J. Nickoloff, and T.S. Frank Detection of human papillomavirus DNA in keratoacanthomas by polymerase chain reaction Am J Dermatopathol 19 1997 10 15
13. K.L. Magee, R.P. Rapini, M. Duvic, and K. Adler-Storthz Human papillomavirus associated with keratoacanthoma Arch Dermatol 125 1989 1587 1589